Zimmer Biomet Earns 510(k) for G7 TM Acetabular System .

Zimmer Biomet has received FDA 510(k) clearance for its G7 TM Acetabular System, expanding the company’s portfolio of hip arthroplasty solutions. The system incorporates trabecular metal (TM) technology designed to enhance biologic fixation through a highly porous structure that promotes bone ingrowth and long-term implant stability. Engineered to provide improved load distribution and durable fixation, the implant is intended to support both primary and complex hip replacement procedures. The clearance highlights the continued evolution of implant materials and surface technologies aimed at improving osseointegration and longevity in hip arthroplasty. As manufacturers refine implant design and biomaterials, these advances are helping drive the next generation of hip replacement technologies.